D&DIAGNOSIS & EARLY DETECTION
Diagnosis & Early Detection/October 2, 2026/3 min read

Severe Diabetes Onset Linked to Higher Risk of Eye Complications Later

A new study of over 3,500 adults with Type 1 diabetes found that those who had a severe diabetic emergency (ketoacidosis) at diagnosis were more likely to develop retinopathy—damage to the blood vessels in the eye—years later.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningautoantibodiesstaging

Key takeaways

  • About 1 in 10 people with Type 1 diabetes had a severe episode requiring ICU care at onset, usually diabetic ketoacidosis.
  • Adults who experienced this severe inaugural event showed higher rates of retinopathy (eye damage) compared to those with milder onsets.
  • The link between severe onset and eye complications was especially strong in people diagnosed before age 17.
  • Severe hypoglycaemic episodes (dangerously low blood sugar) in the past year were also more common in the ICU group.

When Type 1 Diabetes Begins in Crisis

Type 1 diabetes can announce itself dramatically. Some people arrive at the hospital in a life-threatening state called diabetic ketoacidosis (DKA)—when the body produces too much acid and blood sugar spirals out of control. Others have a quieter diagnosis. A new study examined whether this harsh beginning sets people up for more complications down the road.

Researchers looked at data from 3,548 adults with Type 1 diabetes, most of whom had lived with the disease for about 20 years. One in ten (377 people) had experienced a severe episode serious enough to require intensive care when their diabetes was first diagnosed. The study team compared long-term health outcomes between these two groups.

Eye Complications More Common After Severe Onset

The most striking finding involved retinopathy—damage to the blood vessels at the back of the eye that can lead to vision problems. Among those with a severe ICU admission at diagnosis, 36.6% had developed retinopathy by the time of the study. In contrast, 31.4% of those without a severe onset had retinopathy. The difference was even clearer for more advanced forms: 11.1% of the ICU group had proliferative retinopathy (a more serious stage) compared to 7.7% in the other group.

These differences held true even after researchers adjusted for other factors that affect complications—including blood sugar control (HbA1c), age, smoking, how long someone has had diabetes, and education level. The link was especially pronounced in people who were diagnosed before age 17.

Other Complications and Risk Patterns

Severe hypoglycaemia (dangerously low blood sugar episodes) in the year before the study was also more common in the group that had an ICU admission at diagnosis: 15.4% versus 10.5%. This difference remained significant after adjusting for other variables.

The study did not find clear differences in other long-term complications between the two groups, though researchers note that their analysis was still ongoing for some outcomes.

What This Means for Diagnosis and Follow-Up

This research adds to existing evidence that how Type 1 diabetes first appears—especially if it involves a severe metabolic emergency—may influence health outcomes years later. While the reasons are not yet fully understood, a severe onset could reflect more aggressive disease biology, delays in diagnosis, or other unmeasured factors.

For people with Type 1 diabetes who had a dramatic or severe diagnosis, this study suggests the importance of consistent, careful monitoring—particularly of eye health through regular retinopathy screening. It also underscores the value of glucose management and hypoglycaemia awareness to prevent both acute crises and long-term damage.

Evidence label

Source: Diabetes, obesity & metabolism. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.